Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~22 mi. (Saint-Herblain, France, +226 more cities)

Institut De Cancerologie De L Ouest ( Site 0448)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

~22 mi. (Saint-Herblain, France, +45 more cities)

Institut De Cancerologie De L Ouest ( Site 1003)

Esophageal Squamous Cell Carcinoma

cisplatin, +5 more drugs

chemotherapy, +2 more types

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

~22 mi. (Saint-Herblain, France, +122 more cities)

Institut De Cancerologie De L Ouest ( Site 1110)

Small Cell Lung Carcinoma

etoposide, +5 more drugs

chemotherapy, +3 more types

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

~22 mi. (Saint-Herblain, France, +202 more cities)

Site FR33101

CLDN18 Expression, +1 more biomarker

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

modified FOLFOX6 regimen, +1 more drug

chemotherapy, +1 more type

Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)

~22 mi. (Saint-Herblain, France, +105 more cities)

Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 0455)

Colorectal Adenocarcinoma

bevacizumab, +1 more drug

targeted therapy

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

~22 mi. (Saint-Herblain, France, +15 more cities)

Institut de Cancérologie de l'Ouest

KIT Expression

Gastrointestinal Stromal Tumor

imatinib

targeted therapy

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

~22 mi. (Saint-Herblain, France, +24 more cities)

Institut de Cancérologie de l'Ouest René Gauducheau /ID# 212880

ER Negative, +2 more biomarkers

Breast Adenocarcinoma, +2 more conditions

ABBV-368, +5 more drugs

chemotherapy, +1 more type

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

~22 mi. (Saint-Herblain, France, +7 more cities)

ICO Centre René Gauducheau

Gastrointestinal Stromal Tumor

lenvatinib, +1 more drug

Other, +1 more type

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~28 mi. (Nantes, France, +176 more cities)

Hopital prive du Confluent ( Site 2061)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

~28 mi. (Nantes, France, +163 more cities)

CHU Hotel Dieu Nantes ( Site 0458)

Bladder Urothelial Carcinoma

cystectomy, +2 more drugs

chemotherapy, +3 more types

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~28 mi. (Nantes, France, +131 more cities)

CHU Hotel Dieu Nantes ( Site 1101)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~28 mi. (Nantes, France, +126 more cities)

CHU Hotel Dieu Nantes ( Site 0230)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types